122 related articles for article (PubMed ID: 21999122)
1. American Society of Clinical Oncology 2011 CNS tumors update.
Ahluwalia MS
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1495-7. PubMed ID: 21999122
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology 2010: report of selected studies from the CNS tumors section.
Wen PY
Expert Rev Anticancer Ther; 2010 Sep; 10(9):1367-9. PubMed ID: 20836670
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of temozolomide plus concurrent whole-brain radiation followed by TNV regimen as adjuvant therapy for patients with newly diagnosed primary CNS lymphoma.
Wang Y; Liu B; Xu D; Zhao H; Zhu Y; Xu J; Tao R
Neurol India; 2013; 61(3):260-4. PubMed ID: 23860145
[TBL] [Abstract][Full Text] [Related]
4. Treatment of newly diagnosed glioblastoma multiforme.
Nieder C
J Clin Oncol; 2002 Jul; 20(14):3179-80; author reply 3181-2. PubMed ID: 12118034
[No Abstract] [Full Text] [Related]
5. Glioblastoma--more questions than answers?
Reardon DA
Nat Clin Pract Oncol; 2006 Feb; 3(2):60-1. PubMed ID: 16462825
[No Abstract] [Full Text] [Related]
6. Primary central nervous system lymphoma treated with rituximab plus temozolomide in a second line schedule.
Santisteban M; Nieto Y; De la Cruz S; Aristu J; Zubieta JL; Fernández Hidalgo O
Clin Transl Oncol; 2007 Jul; 9(7):465-7. PubMed ID: 17652061
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide for the treatment of metastatic melanoma: a systematic review.
Quirt I; Verma S; Petrella T; Bak K; Charette M
Oncologist; 2007 Sep; 12(9):1114-23. PubMed ID: 17914081
[TBL] [Abstract][Full Text] [Related]
8. Population-based survival analyses of central nervous system tumors from 1994 to 2008. An up-dated study in the temozolomide-era.
Fuentes-Raspall R; Puig-Vives M; Guerra-Prio S; Perez-Bueno F; Marcos-Gragera R
Cancer Epidemiol; 2014 Jun; 38(3):244-7. PubMed ID: 24794586
[TBL] [Abstract][Full Text] [Related]
9. Post-operative management of primary glioblastoma multiforme in patients over 60 years of age.
Daróczi B; Szántó E; Tóth J; Barzó P; Bognár L; Bakó G; Szántó J; Mózes P; Hideghéty K
Ideggyogy Sz; 2013 Nov; 66(11-12):391-8. PubMed ID: 24555238
[TBL] [Abstract][Full Text] [Related]
10. Promising survival and concomitant radiation plus temozolomide followed by adjuvant temozolomide.
Beauchesne P
J Clin Oncol; 2002 Jul; 20(14):3180-1; author reply 3181. PubMed ID: 12118035
[No Abstract] [Full Text] [Related]
11. Going past the data for temozolomide.
Villano JL; Letarte N; Bressler LR
Cancer Chemother Pharmacol; 2012 Apr; 69(4):1113-5. PubMed ID: 22147076
[TBL] [Abstract][Full Text] [Related]
12. Drug Insight: temozolomide as a treatment for malignant glioma--impact of a recent trial.
Mason WP; Cairncross JG
Nat Clin Pract Neurol; 2005 Dec; 1(2):88-95. PubMed ID: 16932504
[TBL] [Abstract][Full Text] [Related]
13. Commentary on Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459-466).
Linz U
Cancer; 2010 Apr; 116(8):1844-6. PubMed ID: 20151424
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide in patients with high grade gliomas.
Brandes AA; Pasetto LM; Vastola F; Monfardini S
Oncology; 2000 Sep; 59(3):181-6. PubMed ID: 11053983
[TBL] [Abstract][Full Text] [Related]
15. Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas.
Wong ET; Tishler R; Barron L; Wu JK
Cancer; 2004 Jul; 101(1):139-45. PubMed ID: 15221999
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly population.
Alliot C
Cancer; 2004 Dec; 101(12):2897-8; author reply 2898-9. PubMed ID: 15526295
[No Abstract] [Full Text] [Related]
17. Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide.
Nagane M; Kobayashi K; Ohnishi A; Shimizu S; Shiokawa Y
Jpn J Clin Oncol; 2007 Dec; 37(12):897-906. PubMed ID: 18156172
[TBL] [Abstract][Full Text] [Related]
18. Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly.
Omuro AM; Taillandier L; Chinot O; Carnin C; Barrie M; Hoang-Xuan K
J Neurooncol; 2007 Nov; 85(2):207-11. PubMed ID: 17896079
[TBL] [Abstract][Full Text] [Related]
19. Medical oncology: treatment and management of malignant gliomas.
Park DM; Sathornsumetee S; Rich JN
Nat Rev Clin Oncol; 2010 Feb; 7(2):75-7. PubMed ID: 20118976
[No Abstract] [Full Text] [Related]
20. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
